DESCRIPCIÓN

FLEXOST está indicado para el tratamiento y la prevención de la osteoartritis. Su composición se formula a partir de 220 ​​mg de sulfato de productos naturales de glucosamina, la condroitina 220mg.



ADVERTENCIAS


En la mayoría de los estudios en humanos, el sulfato de glucosamina ha sido bien tolerado por 30 a 160 días.

Los efectos secundarios pueden incluir malestar estomacal, somnolencia, insomnio, dolor de cabeza, reacciones en la piel, sensibilidad al sol, con uñas y endurecimiento. Hay informes poco frecuentes de dolor abdominal, pérdida de apetito, vómitos, náuseas, flatulencia (gases), estreñimiento, acidez estomacal y diarrea. Sobre la base de varios casos en humanos, el aumento temporal de la presión arterial y frecuencia cardiaca, así como palpitaciones, puede ocurrir con glucosamina / condroitina productos. Con base en investigaciones en animales, teóricamente la glucosamina puede incrementar el riesgo de formación de cataratas.

PRECAUTIONS

Allergies

Since glucosamine can be made from the shells of shrimp, crab, and other shellfish, people with shellfish allergy or iodine hypersensitivity may have an allergic reaction to glucosamine products. However, some research suggests that there is not enough shrimp allergen in glucosamine supplements to trigger reactions in patients who are allergic to shrimp. Nevertheless, caution is warranted. A serious hypersensitivity reaction including throat swelling has been reported with glucosamine sulfate. There are reported cases suggesting a link between glucosamine/chondroitin products and asthma exacerbations.

MISUSE POTENTIAL

No potential for misuse has been experienced in pre marketing clinical studies or during post marketing events.

USE IN SPECIAL POPULATIONS

Pregnancy

No adequate and well controlled studies with FLEXOST have been conducted in pregnant women.  Because animal reproductive studies are not always predicative of human response FLEXOST during pregnancy is not recommended. 

Nursing Mothers

It is not known if FLEXOST is secretes in human milk.  Therefore, FLEXOST should not be taken by nursing women. 

Pediatric Use

FLEXOST has not been studied in pediatric patients below the age of 16 years. There is not enough scientific evidence to recommend the use of glucosamine in children.

Geriatric Use

Clinical studies of FLEXOST included significant number of patients aged 65 years and older which determined the resonance was similar to younger patients.